BNF 9: Blood and Nutrition

Size: px
Start display at page:

Download "BNF 9: Blood and Nutrition"

Transcription

1 FORMULARY CHOICE RESTRICTED 1 Blood and Blood-Forming Organs 1.1 Anaemias Epoetins Epoetinalfa pre-filled (Eprex ) 1,000unit 2,000unit 3,000unit 4,000unit 5,000unit 6,000unit 8,000unit 10,000unit 20,000unit 30,000unit 40,000unit Methoxy polyethylene glycol-epoetin beta prefilled (Mircera ) 30microg 50microg 75microg 100microg 120microg 150microg 200microg 250microg 360microg 1.2 Anaemias, Iron Deficiency Iron, Injectable Ferric Carboxymaltose (Ferrinject ) 1000mg/20ml Specialist use Page 1 of 10 Restricted to the treatment of anaemias associated with chronic renal failure. A small amount of specialist prescribing to treat symptomatic anaemia in adults receiving cancer chemotherapy NICE TA323 Specialist use Restricted to the treatment of anaemias associated with chronic renal failure. Specialist use in accordance with agreed Trust guidance and specific prescribing proformas.

2 100mg/2ml 500mg/10ml Iron Dextran 100mg/2ml (Cosmofer ) Iron Sucrose 100mg/5ml (Venofer ) Iron, Oral Ferrous Sulfate 200mg tablet 325mg m/r tablet Ferrous Fumarate 210mg tablet 322mg tablet 140mg/5ml syrup Ferrous Gluconate 300mg tablet Sodium Feredetate 190mg/5ml elixir Ferrous Fumarate 305mg / folic acid 350microg tablet Ferrous Fumarate 322mg / folic acid 350microg tablet 1.3 Anaemias, Megaloblastic Folates Folic acid 400microg tablet 5mg tablet 2.5mg/5ml syrup Folic acid 15mg/ml Vitamin B Group Hydroxocobalamin 1mg/ml 1.5 Iron Overload Iron Chelators Page 2 of 10 Specialist use in accordance with agreed Trust guidance and specific prescribing proformas. Specialist use in accordance with agreed Trust guidance and specific prescribing proformas. Specialist use; usually within the Critical Care setting.

3 Desferrioxamine 500mg powder for 2g powder for 1.6 Neutropenia Specialist and Emergency Use Only to treat iron overload. Granulocyte-Colony Stimulating Factors Filgrastim 30millionunits (300microg)/ml Specialist use in the treatment of neutropenia; taking account of Trust Guidelines for the use of Colony Stimulating factors for Oncology and Haematology Patients. Lenograstim 13.4million-units powder for 33.6million-units powder for Pegfilgrastim 6mg/0.6ml Specialist use in the treatment of neutropenia; taking account of Trust Guidelines for the use of Colony Stimulating factors for Oncology and Haematology Patients. Specialist use in the treatment of neutropenia; taking account of Trust Guidelines for the use of Colony Stimulating factors for Oncology and Haematology Patients. 1.8 Platelet Disorders Cyclic AMP Phosphodiesterase III Inhibitors Anagrelide 500microg capsule Very specialist use for the treatment of essential thrombocythaemia. Thrombopoietin Receptor Agonists Eltrombopag 25mg tablet 50mg tablet Romiplostim 250 microgam 2 Fluid and Electrolyte Imbalances Bicarbonate Sodium bicarbonate 500mg capsule Sodium bicarbonate 1.4% 500ml Consultant Haematologist initiation only. Very specialist use in accordance with NICE TA293, noting NICE TA382 Very specialist use in accordance with NICE TA221 Page 3 of 10

4 4.2% 500ml 8.4% 200ml 4.2% 10ml 8.4% 10ml 8.4% 50ml prefilled Oral Rehydration Salts Dioralyte sachet Potassium 0.6% sodium chloride, 0.32% sodium lactate, 0.04% potassium chloride and 0.027% calcium chloride, 1000ml (Hartmann s Solution) Potassium chloride 20mmol in 5% glucose 1000ml 40mmol in 5% glucose 1000ml Potassium chloride in 0.9% sodium chloride 20mmol 500ml 20mmol 1000ml 40mmol 1000ml Potassium chloride in 0.45% sodium chloride and 5% glucose 20mmol 500ml 10mmol 500ml Potassium chloride in 0.18% sodium chloride and 4% glucose 20mmol 500ml Page 4 of 10

5 10mmol 500ml Potassium chloride 0.15% (10mmol) in glucose 10% - 500mls Potassium Chloride 15% Concentrate 10ml ampoule Sodium Sodium chloride 600mg tablet 0.9% sodium chloride 50ml 100ml 250ml 500ml 1000ml 5ml 10ml 20ml 0.18% sodium chloride and 4% glucose 500ml 1000ml 0.9% sodium chloride and 5% glucose 500ml 0.45% sodium chloride and 5% glucose 500ml Sugars Glucose 5% 250ml 5% 500ml 10% 500ml 20% 500ml 20% 20ml Very limited and strictly controlled usage Only to be utilised in accordance with the Trust s Potassium Chloride Concentrate Injection Protocol and associated Controlled Drug procedures t commonly used Page 5 of 10

6 50% 500ml 50% 50ml 2.1 Calcium Imbalance Hypercalcaemia and Hypercalciurua Calcimimetic Agents Cinacalcet 30mg tablet Specialist use only - in accordance with agreed Shared Care Guideline when treating Primary Hyperparathyroidism. Etelcalcetide 2.5 mg solution for 5 mg 10 mg solution for Hypocalcaemia Calcium Calcium carbonate 1.25g eff. tablet Calcium carbonate 1.25g tablet Calcium compound 1000mg tablet Calcium Gluconate 10% Calcium Chloride 10% 2.2 Low Blood Volume Plasma Products Human Albumin 4.5% 100ml solution 4.5% 500ml solution 20% 100ml solution 20% 500ml solution Consultation initiation only in renal patients, in accordance with NICE guidance NICE TA117 Specialist use only in accordance with NICE TA448 Page 6 of 10

7 Plasma Substitutes Dextran 40 in 5% glucose 500ml 70 in 5% glucose 500ml 70 in 0.9% sodium chloride 500ml Gelatin (Gelaspan ) 500ml 2.3 Magnesium Imbalance Hypomagnesaemia Magnesium Magnesium Glycerophosphate 4mmol tablet 4mmol/5ml solution Magnesium Sulfate 50% 2ml 10ml 2.4 Phosphate Imbalance Hyperphosphataemia Calcium Calcium Acetate 1g tablet Phosphate Binders Calcium Carbonate 1.25g tablet (Calcichew ) Sevelamer 800mg tablet (Renvela ) 2.4g sachet (Renvela ) Lanthanum (Fosrenol ) 500mg tablet 750mg tablet 1000mg tablet Hypophosphataemia Page 7 of 10 Unlicensed products, but relatively widely used to treat hypomagnesaemia Specialist prescribing under the control of the Trust s Renal Team Specialist prescribing under the control of the Trust s Renal Team Specialist prescribing under the control of the Trust s Renal Team Specialist prescribing under the control of the Trust s Renal Team

8 Phosphates Phosphate compound 1.936g dispersible tablet Phosphate 500ml Polyfusor 2.5 Potassium Imbalance Hyperkalaemia Cation Exchange Resins Calcium Resonium powder Resonium A Limited use within renal patients. Hypokalaemia Potassium Potassium chloride 1mmol/ml syrup Potassium bicarbonate / potassium chloride 12mmol tablet 6 Vitamin Deficiency Multivitamins Vitamin Compound tablet Vitamin A, B and C drop (Abidec and Dalivit ) Forceval capsule Junior capsule Renavit tablet Specialist prescribing under the control of the Trust s Renal Team Aquadeks liquid Specialist prescribing - for cystic fibrosis patients only Vitamin B Group Pyridoxine 10mg tablet 50mg tablet Thiamine 100mg tablet Vitamin B Compound Strong tablet Pabrinex high potency intravenous Page 8 of 10

9 intramuscular Vitamin C Ascorbic Acid 50mg tablet 500mg tablet Vitamin D and Analogues Alfacalcidol 250nanog capsule 1microg capsule 2microg/ml oral drop 2microg/ml Calcitriol 250nanog capsule Colecalciferol 20,000 unit capsule (Pro D3l ) Calcium and ergocaliferol tablet Calcium Carbonate 1.5g / Colecalciferol 10microg tablet (Adcal D3 ) Calcium Carbonate 1.5g / Colecalciferol 10 microg eff. tablet (Adcal D3 Dissolve ) Calcium Carbonate 2.5g / Colecalciferol 22 microg tablet (theical- D3 ) Vitamin E Vitamin E 500mg/5ml suspension Vitamin K Menadiol phosphate 10mg tablet Phytomenadione 10mg tablet Phytomenadione 10mg/ml (Konakion MM) Phytomenadione Page 9 of 10 Unlicensed but only currently available oral vitamin D Only for patients unable to tolerate and be concordant with Adcal D3 tablets.

10 2mg/0.2ml (Konakion MM paediatric) Page 10 of 10

Report generated from BNF provided by FormularyComplete ( Accessed TA Number. Title Formulary Status Section

Report generated from BNF provided by FormularyComplete (  Accessed TA Number. Title Formulary Status Section Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed 16 02 2017 Title Formulary Status Section TA Number TA Link Annotation Abidec Adcal-D3 Addiphos Additrace 9.6 Vitamins->9.6.7

More information

Report generated from MPH Formulary provided by FormularyComplete ( Accessed Formulary Status. TA Number.

Report generated from MPH Formulary provided by FormularyComplete (  Accessed Formulary Status. TA Number. Report generated from MPH provided by Complete (www.pharmpress.com). Accessed 18 01 2016 Title Status Section TA Number TA Link Colecalciferol No UK PL 9.6 Vitamins->9.6.4 Vitamin D->COLECALCIFEROL Colecalciferol

More information

Chapter 9 Nutrition and Blood

Chapter 9 Nutrition and Blood Chapter 9 page number 1 Chapter 9 Nutrition and Blood First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both primary

More information

Chapter 9 Nutrition and Blood

Chapter 9 Nutrition and Blood Chapter 9 page number 1 Chapter 9 Nutrition and Blood First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both primary

More information

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies Contents: Blood disorders 1 1. Anaemia 2 A. Non-renal patients 2 B. Patients with chronic kidney disease under the care of

More information

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies Contents: Blood disorders 1 1. Anaemia 2 A. Non-renal patients 2 B. Patients with chronic kidney disease under the care of

More information

Nutrition 1 1. Total parenteral nutrition (TPN) 2 2. Enteral nutrition 2 3. Coeliac disease 3

Nutrition 1 1. Total parenteral nutrition (TPN) 2 2. Enteral nutrition 2 3. Coeliac disease 3 Medicines Formulary Nutrition, blood and electrolyte disorders Contents: Nutrition 1 1. Total parenteral nutrition (TPN) 2 2. Enteral nutrition 2 3. Coeliac disease 3 Blood disorders 3 4. Anaemia 3 A.

More information

9. Nutrition and blood

9. Nutrition and blood 9. Nutrition and blood 1 9.1 - Anaemia and some other blood disorders 9.1.1 Iron deficiency anaemias 9.1.1.1 Oral Iron Ferrous fumarate Ferrous sulfate Sodium feredetate (Sytron ) Haemoglobin should rise

More information

9: Nutrition and blood

9: Nutrition and blood Original date of issue: 30/01/2006 Last Reviewed: 17/09/2011 Version:4 Page 1 of 18 9: Nutrition and blood 9.1 Anaemias and some other blood disorders 9.1.1 Iron-deficiency anaemias 9.1.1.1 Oral iron Iron

More information

BNF CHAPTER 9: NUTRITION & BLOOD

BNF CHAPTER 9: NUTRITION & BLOOD 9.1 ANAEMIAS BNF CHAPTER 9: NUTRITION & BLOOD 9.1.1 IRON-DEFICIENCY ANAEMIAS 9.1.1.1 ORAL IRON Use of modified release iron preparations is not recommended since these preparations release iron beyond

More information

First line drugs Second line drugs Specialist drugs Hospital only drugs

First line drugs Second line drugs Specialist drugs Hospital only drugs CHAPTER 9 NUTRITION AND BLOOD First line drugs drugs recommended in both primary and secondary care Second line drugs alternatives (often in specific conditions) in both primary and secondary care Specialist

More information

Kent Kidney Care Centre: Medicines prescribed for people with chronic kidney disease

Kent Kidney Care Centre: Medicines prescribed for people with chronic kidney disease Kent Kidney Care Centre: Medicines prescribed for people with chronic kidney disease Information for patients The following pages offer you information on some of the medicines that you may need. It is

More information

GUIDANCE NOTES. DIETETIC RISK ASSESSMENT FOR REFEEDING RECOMMENDED MEAL PLANS When commencing re-feeding: NICE (2006)

GUIDANCE NOTES. DIETETIC RISK ASSESSMENT FOR REFEEDING RECOMMENDED MEAL PLANS When commencing re-feeding: NICE (2006) When commencing re-feeding: NICE (2006) NICE (2006) Clinical Guideline 32 Nutrition support in adults: oral nutrition support, enteral tube feeding and parenteral nutrition (The following is based on www.nice.org.uk/cg032

More information

VITAMIN D DEFICIENCY IN CHILDREN AND ADULTS: TREATMENT AND PROPHYLAXIS GUIDELINE

VITAMIN D DEFICIENCY IN CHILDREN AND ADULTS: TREATMENT AND PROPHYLAXIS GUIDELINE VITAMIN D DEFICIENCY IN CHILDREN AND ADULTS: TREATMENT AND PROPHYLAXIS GUIDELINE SECTION A. DEFINITION AND DIAGNOSIS The main source of vitamin D is from the action of UVB sunlight on the skin, which results

More information

NOTTINGHAMSHIRE AREA PRESCRIBING COMMITTEE SHARED CARE PROTOCOL AGREEMENT

NOTTINGHAMSHIRE AREA PRESCRIBING COMMITTEE SHARED CARE PROTOCOL AGREEMENT NOTTINGHAMSHIRE AREA PRESCRIBING COMMITTEE SHARED CARE PROTOCOL AGREEMENT Phosphate Binders for the Treatment of Hyperphosphataemia in adults with Chronic Kidney Disease OBJECTIVES To outline referral

More information

Kidney damage with normal or increased GFR Kidney damage with mild reduction in GFR

Kidney damage with normal or increased GFR Kidney damage with mild reduction in GFR CHRONIC KIDNEY DISEASE Contents Stages of Chronic Kidney Disease Dosing adjustments Hyperphosphataemia management Secondary hyperparathyroidism Anaemias Hyperkalaemia Acidosis Hypertension STAGES OF CHRONIC

More information

Medicines for anaemia and mineral bone disease

Medicines for anaemia and mineral bone disease Patient Information: Medicines NHS Logo here Medicines for anaemia and mineral bone disease Health & care information you can trust The Information Standard Certified Member Working together for better

More information

378FM.2 VITAMIN SUPPLEMENTATION FOR PAEDIATRIC CYSTIC FIBROSIS (CF) PATIENTS

378FM.2 VITAMIN SUPPLEMENTATION FOR PAEDIATRIC CYSTIC FIBROSIS (CF) PATIENTS 378FM.2 VITAMIN SUPPLEMENTATION FOR PAEDIATRIC CYSTIC FIBROSIS (CF) PATIENTS Oxford University Hospitals and the Royal Brompton are the tertiary CF centres serving Buckinghamshire. Many patients are under

More information

***II POSITION OF THE EUROPEAN PARLIAMENT

***II POSITION OF THE EUROPEAN PARLIAMENT EUROPEAN PARLIAMENT 1999 2004 Consolidated legislative document 13 March 2002 2000/0080(COD) PE2 ***II POSITION OF THE EUROPEAN PARLIAMENT adopted at second reading on 13 March 2002 with a view to the

More information

Contents. Authors Name: Christopher Wong: Consultant Nephrologist Anne Waddington: Renal Pharmacist Eimear Fegan : Renal Dietitian

Contents. Authors Name: Christopher Wong: Consultant Nephrologist Anne Waddington: Renal Pharmacist Eimear Fegan : Renal Dietitian Cheshire and Merseyside Renal Units Guidelines on the Management of Chronic Kidney Disease - Mineral Bone Disorder (adapted from Greater Manchester) Authors Name: Christopher Wong: Consultant Nephrologist

More information

Medibios Laboratories Private Limited, India Nutraceutical / OTC & Cosmetics product List Product Description

Medibios Laboratories Private Limited, India Nutraceutical / OTC & Cosmetics product List Product Description Sr. No. Medibios Laboratories Private Limited, India Product Description 1 Calcium with Vitamin D3 and Mineral Tablets Each film-coated tablet contains: Calcium Carbonate BP equivalent to Elemental Calcium

More information

FM-IN-FC-01 Rev.1. PDF processed with CutePDF evaluation edition

FM-IN-FC-01 Rev.1. PDF processed with CutePDF evaluation edition ก 2553 ก ก ก (DIRECTIVE 2002/46/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCILof 10 June 2002 on the approximation of the laws of the Member States relating to food supplements) : ก ก ก ก : ก ก : 10

More information

Chronic Kidney Disease Mineral Bone Disease

Chronic Kidney Disease Mineral Bone Disease NHS Logo here Chronic Kidney Disease Mineral Bone Disease (CKD-MBD) Patient Information Health & care information you can trust The Information Standard Certified Member Working together for better patient

More information

CG1339. Version: Renal Services Group. Approving forum (QIPS or equivalent):

CG1339. Version: Renal Services Group. Approving forum (QIPS or equivalent): University Hospitals Coventry & Warwickshire NHS Trust Clinical Guideline (full) CHRONIC KIDNEY DISEASE (CKD) NUTRITIONAL RECOMMENDATIONS FOR PERITONEAL DIALYSIS E-Library Reference CG1339 Version: Approving

More information

Seven Easy Steps To Assess Non-Compliance Of A Food Supplement

Seven Easy Steps To Assess Non-Compliance Of A Food Supplement Seven Easy Steps To Assess Non-Compliance Of A Food Supplement Three easy immediate checks of the label 1. If a product is labelled as Dietary Supplement, it is non-compliant. All food supplements must

More information

codex alimentarius commission

codex alimentarius commission codex alimentarius commission FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS WORLD HEALTH ORGANIZATION JOINT OFFICE: Viale delle Terme di Caracalla 00100 ROME Tel.: 39.06.57051 Telex: 625825-625853

More information

Clinical Guideline Bone chemistry management in adult renal patients on dialysis

Clinical Guideline Bone chemistry management in adult renal patients on dialysis Clinical Guideline Bone chemistry management in adult renal patients on dialysis This guidance covers how to: Maintain serum phosphate 0.8 to 1.7mmol/L 1 Maintain serum corrected calcium 2.1 to 2.5mmol/L

More information

Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol

Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol This is an official Northern Trust policy and should not be edited in any way Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol Reference Number: NHSCT/12/553 Target

More information

Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol

Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol Nutrition and Dietetic Service Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol Authors Hilary Mathieson, Renal Dietitian Paul McKeveney, Consultant Nephrologist

More information

Module 8: Practice Problems

Module 8: Practice Problems Module 8: Practice Problems 1. Convert a blood plasma level range of 5 to 20 µg/ml of tobramycin (Z = 467.52) to µmol/l. 5 µg/ml = 10.7 µmol/l 20 µg/ml = 42.8 µmol/l 2. A preparation contains in each milliliter,

More information

Start. What is the serum phosphate concentration? Moderate Hypophosphataemia mmol/l. Replace using oral. phosphate. (See section 3.

Start. What is the serum phosphate concentration? Moderate Hypophosphataemia mmol/l. Replace using oral. phosphate. (See section 3. CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPOPHOSPHATAEMIA IN ADULTS Summary. Key: General Notes GP/SWASFT ED/MAU/SRU/Acute GP/Amb-Care In-patient wards Start What is the serum concentration? Mild Hypophosphataemia

More information

FOOD SAFETY ACT (ACT NO. XIV OF 2002) Food Supplements Regulations 2003

FOOD SAFETY ACT (ACT NO. XIV OF 2002) Food Supplements Regulations 2003 L.N. 239 of 2003 FOOD SAFETY ACT (ACT NO. XIV OF 2002) Food Supplements Regulations 2003 IN exercise of the powers conferred by article 10 of the Food Safety Act, the Minister of Health has made the following

More information

Nottingham Renal and Transplant Unit

Nottingham Renal and Transplant Unit Nottingham Renal and Transplant Unit Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if Trust wide): Review date (when this version goes out

More information

CHANGES YOU AND YOUR STAFF NEED TO KNOW ABOUT

CHANGES YOU AND YOUR STAFF NEED TO KNOW ABOUT Taranaki DHB Electronic Discharge Summary & MedRec Upgrade CHANGES YOU AND YOUR STAFF NEED TO KNOW ABOUT Community Pharmacy & GP s November 2015 Overview Taranaki DHB is required to upgrade it s operating

More information

1. Adults; a. Risk factors. b. Who should be tested for vitamin D deficiency? c. Investigations. d. Who do we treat and how do we treat? 2.

1. Adults; a. Risk factors. b. Who should be tested for vitamin D deficiency? c. Investigations. d. Who do we treat and how do we treat? 2. Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management For Adults and Children Adapted from existing local guidance, National Osteoporosis Society Practical Guides and from Royal

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Renvela 2.4 g powder for oral suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet contains 2.4 g sevelamer carbonate.

More information

Fortisip Powder A high energy, high protein, nutritionally complete, powder supplement that can be mixed to desired energy concentration

Fortisip Powder A high energy, high protein, nutritionally complete, powder supplement that can be mixed to desired energy concentration A high energy, high protein, nutritionally complete, powder supplement that can be mixed to desired energy concentration Features Flexibility to prepare to various energy concentrations: 1kcal/ml, 1.5kcal/ml

More information

Northern Treatment Advisory Group

Northern Treatment Advisory Group Northern Treatment Advisory Group Ferric Maltol (Feraccru ) for the treatment of iron deficiency Lead author: Daniel Hill Regional Drug & Therapeutics Centre (Newcastle) September 2018 2018 Summary Iron

More information

Water. Nutrition Facts Serving Size 20 fl oz (591 ml) Servings Per Container 1. Amount Per Serving Calories 0 Calories from Fat 0

Water. Nutrition Facts Serving Size 20 fl oz (591 ml) Servings Per Container 1. Amount Per Serving Calories 0 Calories from Fat 0 Water Serving Size 20 fl oz (591 ml) Servings Per Container 1 Calories 0 Calories from Fat 0 Sodium 0mg 0% Total Carbohydrate 0g 0% Sugars 0g Not a significant source of other nutrients. Ingredients: PURIFIED

More information

Multi-Vitamin PART OF YOUR ESSENTIALS PACK

Multi-Vitamin PART OF YOUR ESSENTIALS PACK Supplement Details Multi-Vitamin PART OF YOUR ESSENTIALS PACK A perfectly balanced all rounder. Our high quality multivitamin gives you a well balanced daily dose of a plethora of essential vitamins and

More information

Health Food Raw Materials Directory (First Batch)

Health Food Raw Materials Directory (First Batch) Attachment Health Food Raw Materials Directory (First Batch) Nutrition Supplement Raw Materials Directory (draft) NO. Name of Raw Material Scope of the Crowd Daily Intake Amount Daily Minimum Amount Daily

More information

GUIDELINES FOR MAINTAINING SERUM CALCIUM FOLLOWING PARATHYROIDECTOMY IN PATIENTS WITH CHRONIC KIDNEY DISEASE RRCV CMG Renal and Transplant Service

GUIDELINES FOR MAINTAINING SERUM CALCIUM FOLLOWING PARATHYROIDECTOMY IN PATIENTS WITH CHRONIC KIDNEY DISEASE RRCV CMG Renal and Transplant Service GUIDELINES FOR MAINTAINING SERUM CALCIUM FOLLOWING PARATHYROIDECTOMY IN PATIENTS WITH CHRONIC KIDNEY DISEASE RRCV CMG Renal and Transplant Service 1. Introduction Secondary hyperparathyroidism is an important

More information

Module 8: Electrolyte Solutions

Module 8: Electrolyte Solutions PHARMACEUTICAL CALCULATIONS FALL 207 Contents General Vocab & Definitions... 2 Milliequivalent Calculations... 2 Millimole and Micromole Calculations... 5 Osmolarity... 6 Daily Water Requirement Calculations

More information

Official Journal of the European Communities

Official Journal of the European Communities L 52/19 COMMISSION DIRECTIVE 2001/15/EC of 15 February 2001 on substances that may be added for specific nutritional purposes in foods for particular nutritional uses (Text with EEA relevance) THE COMMISSION

More information

Refeeding Syndrome Guideline

Refeeding Syndrome Guideline Refeeding Syndrome Guideline Author: Responsible Lead Executive Director: Endorsing Body: Governance or Assurance Committee Pamela Miller Biochemistry Implementation Date: January 2017 Version Number:

More information

Medical therapy of AKI complications. Refik Gökmen AKI Academy 18 October 2014

Medical therapy of AKI complications. Refik Gökmen AKI Academy 18 October 2014 Medical therapy of AKI complications Refik Gökmen AKI Academy 18 October 2014 Medical therapy of AKI complications Hyperkalaemia Volume status, fluid therapy Acidosis Calcium & phosphate Bleeding risk

More information

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents 2001L0015 EN 11.04.2006 002.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B COMMISSION DIRECTIVE 2001/15/EC of 15 February

More information

Greater Manchester Guidelines on the Management of Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD)

Greater Manchester Guidelines on the Management of Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD) Greater Manchester Guidelines on the Management of (CKD-MBD) Classification: Clinical Guideline Lead Author: Smeeta Sinha, Consultant Nephrologist Additional author(s): Elizabeth Lamerton, Renal Pharmacist

More information

Product Information:

Product Information: Product Information: Pro-Phree 1 of 5 Nutrition support of infants and toddlers who require extra calories, minerals, and vitamins and/or protein restriction. Use under medical supervision. Protein-free

More information

Product Nutrition Information

Product Nutrition Information Product Nutrition Information for OTE Sports Nutrition Products OTE ph Neutral Energy Drink Maltodextrin (purified and produced by the partial hydrolysis of a special starch), Fructose, Electrolytes (Sodium

More information

COMMON MEDICINES USED IN CKD CHRONIC KIDNEY DISEASE

COMMON MEDICINES USED IN CKD CHRONIC KIDNEY DISEASE CHRONIC KIDNEY DISEASE 1 This information is intended to help you understand why you need to take your medicines. There are multiple medicines that are used to control the symptoms related to CKD. You

More information

CATEGORY : TABLETS, CAPSULES, LIQUID (FOOD CATEGORY)

CATEGORY : TABLETS, CAPSULES, LIQUID (FOOD CATEGORY) EXPORT PRODUCT LIST CATEGORY : S, S, LIQUID (FOOD CATEGORY) www.xieonlife.com 1 S.NO NAME OF PRODUCT Composi on DOSAGE DOCUMENTS 1 ( An oxidant & Micronutrients Tablets ) Each Film Coated Tablet Contains:

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Reference Number: CP.PMN.04 Effective Date: 11.15.17 Last Review Date: 05.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy for important

More information

Date: 22nd March 2018 Our Ref: FANitaminMGPG/Mar18 Enquiries to Frances Adamson Extension: Direct Line: f.adamsonanhs.

Date: 22nd March 2018 Our Ref: FANitaminMGPG/Mar18 Enquiries to Frances Adamson Extension: Direct Line: f.adamsonanhs. NHS Grampian Westholme Woodend Hospital Queens Road ABERDEEN AB15 6LS NHS Grampian Date: 22nd March 2018 Our Ref: FANitaminMGPG/Mar18 Enquiries to Frances Adamson Extension: 56689 Direct Line: 01224 556689

More information

Common Medication for People Receiving Haemodialysis

Common Medication for People Receiving Haemodialysis Common Medication for People Receiving Haemodialysis Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm

More information

Flavour: Red fruits, peach and passion fruit, orange, lime and grapefruit Package size: 1.7g Pharmaceutical form: Powder

Flavour: Red fruits, peach and passion fruit, orange, lime and grapefruit Package size: 1.7g Pharmaceutical form: Powder Flavour: Red fruits, peach and passion fruit, orange, lime and grapefruit Package size: 1.7g Pharmaceutical form: Powder Isotonic sports drink with added vitamins Energy Mineral is a multipurpose isotonic

More information

CORNWALL & IoS GUIDELINE FOR THE MANAGEMENT OF VITAMIN D DEFICIENCY& INSUFFICIENCY IN ADULTS

CORNWALL & IoS GUIDELINE FOR THE MANAGEMENT OF VITAMIN D DEFICIENCY& INSUFFICIENCY IN ADULTS CORNWALL & IoS GUIDELINE FOR THE MANAGEMENT OF VITAMIN D DEFICIENCY& INSUFFICIENCY IN ADULTS INTRODUCTION Vitamin D is essential for skeletal growth and bone health. Dietary sources in the UK are very

More information

D.K.M COLLEGE FOR WOMEN (AUTONOMOUS) VELLORE-1 DEPARTMENT OF FOODS AND NUTRITION ESSENTIAL OF MICRO NUTRIENTS

D.K.M COLLEGE FOR WOMEN (AUTONOMOUS) VELLORE-1 DEPARTMENT OF FOODS AND NUTRITION ESSENTIAL OF MICRO NUTRIENTS D.K.M COLLEGE FOR WOMEN (AUTONOMOUS) VELLORE-1 DEPARTMENT OF FOODS AND NUTRITION ESSENTIAL OF MICRO NUTRIENTS Class: II M.Sc Subject Code: 15CPFN3A Unit - I (6 Marks Questions) 1. Write a note on performed

More information

NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults. Consultation Group: See Page 4. Review Date: June 2021

NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults. Consultation Group: See Page 4. Review Date: June 2021 NHS...... Grampian NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults Co-ordinators: Consultation Group: Approver:. Senior Medicines Information Pharmacist See Page 4 Medicine

More information

Akums Drugs and Pharmaceuticals Ltd. Plant-1, Quality Control Laboratory, , Sector-6A, I.I.E., SIDCUL, Ranipur, Haridwar

Akums Drugs and Pharmaceuticals Ltd. Plant-1, Quality Control Laboratory, , Sector-6A, I.I.E., SIDCUL, Ranipur, Haridwar Last Amended on - Page 1 of 5 I. DRUGS & PHARMACEUTICALS A. General Tests of Biological Testing for Pharmaceutical Dosage Forms 1. Pharmaceutical Dosage Like Tablet,, Dry Syrup and Oral Suspension Total

More information

ELECTROLYTES RENAL SHO TEACHING

ELECTROLYTES RENAL SHO TEACHING ELECTROLYTES RENAL SHO TEACHING Metabolic Alkalosis 2 factors are responsible for generation and maintenance of metabolic alkalosis this includes a process that raises serum bicarbonate and a process that

More information

Area Drug and Therapeutics Committee Prescribing Supplement No 47 July 2011

Area Drug and Therapeutics Committee Prescribing Supplement No 47 July 2011 Area Drug and Therapeutics Committee Prescribing Supplement No 47 In this issue Drugs reviewed by in May / June 2011 ADTC UPDATES ON DRUGS REVIEWED BY THE SMC The following new drugs have been reviewed

More information

Product Information: Glucerna Therapeutic Nutrition Shake

Product Information: Glucerna Therapeutic Nutrition Shake Product Information: Glucerna Therapeutic Nutrition Shake 1 of 5 GLUCERNA THERAPEUTIC NUTRITION SHAKE has CARBSTEADY, including low glycemic carbohydrates clinically shown to help minimize blood glucose

More information

CAUTION: You must refer to the intranet for the most recent version of this procedural document.

CAUTION: You must refer to the intranet for the most recent version of this procedural document. Procedure for the use of Intravenous Iron Dextran (CosmoFer ) Sharepoint Location Sharepoint Index Directory Clinical Policies and Guidelines General Policies and Guidelines/ Haematology And blood transfusion

More information

RENAL ANAEMIA. South West Renal Training Scheme Cardiff October 2018

RENAL ANAEMIA. South West Renal Training Scheme Cardiff October 2018 RENAL ANAEMIA South West Renal Training Scheme Cardiff October 2018 Dr Soma Meran Clinical Senior Lecturer and Honorary Consultant Nephrologist, University Hospital of Wales. Aims Biology of renal anaemia

More information

PROFESSIONAL INFORMATION

PROFESSIONAL INFORMATION This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use. SCHEDULING STATUS: Unscheduled: Complementary Medicine PROPRIETARY NAME AND DOSAGE FORM: BEROCCA

More information

National Institute for Health and Care Excellence

National Institute for Health and Care Excellence National Institute for Health and Care Excellence 2-year surveillance (2017) Chronic kidney disease: managing anaemia (2015) NICE guideline NG8 Appendix A3: Summary of new evidence from surveillance Diagnostic

More information

Tumour Lysis Syndrome (TLS)

Tumour Lysis Syndrome (TLS) (TLS) Overview: Tumour lysis syndrome refers to a number of metabolic disturbances (hyperuricaemia, hyperphosphataemia, hyperkalaemia and hypocalcaemia) that occur as the result of rapid cell lysis. This

More information

Vitamin D guidance. Main objectives for Vitamin D guidance. Contents. Aim of Guidance. References:

Vitamin D guidance. Main objectives for Vitamin D guidance. Contents. Aim of Guidance. References: Summary guideline Vitamin D guidance January 2011 Main objectives for Vitamin D guidance 6 Promote supplements for all children under 5 years of age. 6 Adequate supplementation during pregnancy and breastfeeding.

More information

Prescribing Guidelines Prescribing arrangement for the management of patients transferring from Secondary Care to Primary Care

Prescribing Guidelines Prescribing arrangement for the management of patients transferring from Secondary Care to Primary Care Berkshire West Integrated Care System Representing Berkshire West Clinical Commisioning Group Royal Berkshire NHS Foundation Trust Berkshire Healthcare NHS Foundation Trust Berkshire West Primary Care

More information

2003 No. 273 FOOD. Food Supplements Regulations (Northern Ireland) 2003 STATUTORY RULES OF NORTHERN IRELAND

2003 No. 273 FOOD. Food Supplements Regulations (Northern Ireland) 2003 STATUTORY RULES OF NORTHERN IRELAND STATUTORY RULES OF NORTHERN IRELAND 2003 No. 273 FOOD Food Supplements Regulations (Northern Ireland) 2003 Made - - - - - 20th May 2003 Coming into operation 1st August 2005 The Department of Health, Social

More information

NHS Grampian Staff Guideline For The Management Of Acute Hypophosphataemia In Adults

NHS Grampian Staff Guideline For The Management Of Acute Hypophosphataemia In Adults NHS Grampian Staff Guideline For The Management Of Acute Hypophosphataemia In Adults Co-ordinators: Medicine Information Pharmacist Consultation Group: See Page 5 Approver: Medicine Guidelines and Policies

More information

CLINICAL GUIDELINES ID TAG

CLINICAL GUIDELINES ID TAG CLINICAL GUIDELINES ID TAG Title: Treatment of Hypomagnesaemia in adults Author: Speciality / Division: Directorate: Dr Peter Sharpe, Dr Neal Morgan, Jillian Redpath Chemical Pathology/Nephrology/Pharmacy

More information

HEALTH SHARE/PROVIDENCE (OHP)

HEALTH SHARE/PROVIDENCE (OHP) HEALTH SHARE/PROVIDENCE (OHP) STEP THERAPY This is a complete list of drugs that have written coverage determination policies. Drugs on this list do not indicate that this particular drug will be covered

More information

Re: Important changes to Fortisip Powder

Re: Important changes to Fortisip Powder 18 June 2014 Dear valued customer Nutricia Ltd 37 Banks Road, Mount Wellington Auckland, New Zealand PO Box 62 523 Greenlane, Auckland 1546 Tel: 0800 688 747 Re: Important changes to Fortisip Powder Nutricia

More information

Refeeding syndrome a practical approach

Refeeding syndrome a practical approach Refeeding syndrome a practical approach PENG pre-bapen Conference Teaching Day Birmingham Monday 20 th November 2017 Rhys White Acting Clinical and Operational Lead Dietitian Guys and St Thomas NHS Foundation

More information

PRODUCT INFORMATION RESONIUM A. Na m

PRODUCT INFORMATION RESONIUM A. Na m PRODUCT INFORMATION RESONIUM A NAME OF THE MEDICINE Non-proprietary Name Sodium polystyrene sulfonate Chemical Structure CH - 2 CH SO 3 Na + n CAS Number 28210-41-5 [9003-59-2] CH 2 CH SO - 3 m DESCRIPTION

More information

NUTRITION FACTS BERRY. Nutrition Facts Serving Size: 1 pouch (2.08 oz/59g) [makes 9 fl oz prepared] Servings Per Container: 14

NUTRITION FACTS BERRY. Nutrition Facts Serving Size: 1 pouch (2.08 oz/59g) [makes 9 fl oz prepared] Servings Per Container: 14 BERRY Potassium 600mg 17% Dietary Fiber 5g 20% CALCIUM CASEINATE, L-GLUTAMINE, L-LYSINE, L-LEUCINE, L-ISOLEUCINE, L-VALINE), CRYSTALLINE FRUCTOSE, MALTODEXTRIN, GUM ARABIC, VITAMIN AND MINERAL MIX (DICALCIUM

More information

Introduction The Role of the Kidneys Drugs used in Renal Disease Drugs and Dialysis Renal Pharmacy Team

Introduction The Role of the Kidneys Drugs used in Renal Disease Drugs and Dialysis Renal Pharmacy Team Introduction The Role of the Kidneys Drugs used in Renal Disease Drugs and Dialysis Renal Pharmacy Team Drugs play a major role in both treating and causing renal disease Doses of some drugs need to be

More information

NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults

NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults Co-ordinators: Sarah Gethings Medicine Information Pharmacist Consultation Group: See Page 4 Approver: Medicine Guidelines and

More information

Nutritional Information

Nutritional Information Nutritional Information Honest Milk Step 1 Infant Formula Milk-based Infant Formula Milk powder for Infants 0-12 Months Indication Honest Milk Step 1 Infant Formula Milk Powder Includes Natural Defense

More information

Calculations Key Drink Label Cards

Calculations Key Drink Label Cards Calculations Key Drink Label Cards Instructor Tips for Drink Label Cards 1. Display Drink Label Cards with sugar cubes representing the teaspoons of sugar in each container. Display should also include

More information

Velphoro (sucroferric oxyhydroxide)

Velphoro (sucroferric oxyhydroxide) STRENGTH DOSAGE FORM ROUTE GPID 500mg chewable tablet oral 36003 MANUFACTURER Fresenius Medical Care North America INDICATION(S) For the control of serum phosphorus levels in patients with chronic kidney

More information

EUROPEAN PARLIAMENT C5-0640/2001. Common position. Session document 2000/0080(COD) 10/12/2001

EUROPEAN PARLIAMENT C5-0640/2001. Common position. Session document 2000/0080(COD) 10/12/2001 EUROPEAN PARLIAMENT 1999 Session document 2004 C5-0640/2001 2000/0080(COD) EN 10/12/2001 Common position adopted by the Council on 3 December 2001 with a view to the adoption of a Directive of the European

More information

Ingredient & Nutritional Information for Total Diet Replacement products

Ingredient & Nutritional Information for Total Diet Replacement products SHAKES Banana Chocolate Strawberry Vanilla SOUP Chicken & Mushroom PORRIDGE Original Flavour BARS Lemon Flavoured Yoghurt bar Peanut Crunch bar Shake Banana Flavour Energy kj 1516 607 kcal 360 144 Fat

More information

NHS Grampian Staff Guideline for the Management of Acute Hypokalaemia in Adults

NHS Grampian Staff Guideline for the Management of Acute Hypokalaemia in Adults NHS Grampian Staff Guideline for the Management of Acute Hypokalaemia in Adults Co-ordinators: Medicines Information Pharmacist Consultation Group: See relevant page in guidance Approver: Medicine Guidelines

More information

Inhaled Therapy - for further information, see LTHT Nebuliser Guidelines for Adults or Children

Inhaled Therapy - for further information, see LTHT Nebuliser Guidelines for Adults or Children Inhaled Therapy - for further information, see LTHT Nebuliser Guidelines for Adults or Children Link to: Adult Nebuliser Guidelines Link to: Paediatric Nebuliser Guidelines and Monographs ANTIBIOTICS/

More information

Potassium Citrate Magnesium Citrate And Vitamin B6 Oral Solution Uses

Potassium Citrate Magnesium Citrate And Vitamin B6 Oral Solution Uses Potassium Citrate Magnesium Citrate And Vitamin B6 Oral Solution Uses Nutritional vitamin supplements found. Potassium Citrate Magnesium Citrate and Vitamin B6 oral solution. Linked uses - Promoting Healing

More information

DBL MAGNESIUM SULFATE CONCENTRATED INJECTION

DBL MAGNESIUM SULFATE CONCENTRATED INJECTION DBL MAGNESIUM SULFATE CONCENTRATED INJECTION NAME OF MEDICINE Magnesium Sulfate BP DESCRIPTION DBL Magnesium Sulfate Concentrated Injection is a clear, colourless, sterile solution. Each ampoule contains

More information

Kimberly Tierney Bio-Nutrition

Kimberly Tierney Bio-Nutrition Kimberly Tierney Bio-Nutrition Analysis, evaluation and conclusion of nutrient content and formulation of three separate multivitamins and assessing the adequacy for a thirty year old male and a twenty

More information

Vitamin and Mineral Supplementation and Monitoring. Bariatric Surgery

Vitamin and Mineral Supplementation and Monitoring. Bariatric Surgery Vitamin and Mineral Supplementation and Monitoring Bariatric Surgery We put our patients first by working as one team; leading and listening, and striving for the best. Together, we make the difference.

More information

Product Information: Phenex -1

Product Information: Phenex -1 Product Information: Phenex -1 1 of 5 For nutrition support of infants and toddlers with phenylketonuria (PKU). Phenylalanine-free Use under medical supervision. Phenylalanine-free to allow greater intake

More information

Haemotonics (Agents Used in Anemias; Hematopoietic and Growth Factors) Dr Laith M Abbas Al-Huseini M.B.Ch.B, M.Sc., M.Res., Ph.D.

Haemotonics (Agents Used in Anemias; Hematopoietic and Growth Factors) Dr Laith M Abbas Al-Huseini M.B.Ch.B, M.Sc., M.Res., Ph.D. Haemotonics (Agents Used in Anemias; Hematopoietic and Growth Factors) Dr Laith M Abbas Al-Huseini M.B.Ch.B, M.Sc., M.Res., Ph.D. Iron Kinetics: iron absorption takes place predominantly in the duodenum

More information

Drugs affecting the blood

Drugs affecting the blood Drugs affecting the blood Antianaemia drugs IRON-DEFICIENCY ANAEMIA Anaemia has many different aetiologies. It occurs when the haemoglobin concentration falls below the normal range for the age and sex

More information

COMMISSION REGULATION (EC)

COMMISSION REGULATION (EC) 14.10.2009 Official Journal of the European Union L 269/9 COMMISSION REGULATION (EC) No 953/2009 of 13 October 2009 on substances that may be added for specific nutritional in foods for particular nutritional

More information

TIP Paclitaxel, Ifosfamide and Cisplatin

TIP Paclitaxel, Ifosfamide and Cisplatin Systemic Anti Cancer Treatment Protocol TIP Paclitaxel, Ifosfamide and Cisplatin PROTOCOL REF: MPHATIPGC (Version No: 1.0) Approved for use in: Second line treatment of germ cell tumours Dosage: Drug Dosage

More information

Product Information: Tyrex -1

Product Information: Tyrex -1 Product Information: Tyrex -1 1 of 5 Nutrition support of infants and toddlers with tyrosinemia types I, II or III. Phenylalanine- and tyrosine-free. Use under medical supervision. Phenylalanine- and tyrosine-free

More information

Product Category: Pulmocare

Product Category: Pulmocare Product Category: Pulmocare Pulmocare Updated 4/8/2014 Product Information: Pulmocare 1 of 5 PULMOCARE is designed for people with chronic obstructive pulmonary disease (COPD), cystic fibrosis, or respiratory

More information

Calculations Key Drink Label Cards

Calculations Key Drink Label Cards Calculations Key Drink Label Cards Recommended Uses for Drink Label Cards 1. Display Drink Label Cards with sugar cubes representing the teaspoons of sugar in each container. Be sure to also include MyPlate

More information